Abstract:Carbon dots (CDs) are carbon nano materials (CNMs) that find use across several biological applications because of their water solubility, biocompatible nature, eco-friendliness, and ease of synthesis. Additionally, their physiochemical properties can be chemically tuned for further optimization towards specific applications. Here, we investigate the efficacy of C70-derived Graphene Acid Quantum Dots (GAQDs) in mitigating the transformation of soluble, monomeric Hen Egg-White Lysozyme (HEWL) to mature fibrils during its amyloidogenic trajectory. Our findings reveal that GAQDs exhibit dose-dependent inhibition of HEWL fibril formation (up to 70 % at 5 mg/mL) without affecting mitochondrial membrane potential or inducing apoptosis at the same density. Furthermore, GAQDs scavenged reactive oxygen species (ROS); achieving a 50 % reduction in ROS levels at a mere 100 µg/mL when exposed to a standard free radical generator. GAQDs were not only found to be biocompatible with a human neuroblastoma-derived SHSY-5Y cell line but also rescued the cells from rotenone-induced apoptosis. The GAQD-tolerance of SHSY-5Y cells coupled with their ability to restitute cells from rotenone-dependent apoptosis, when taken in conjunction with the biocompatibility data, indicate that GAQDs possess neuroprotective potential. The data position this class of CNMs as promising candidates for resolving aberrant cellular outputs that associate with the advent and progress of multifactorial neurodegenerative disorders including Parkinson's (PD) and Alzheimer's diseases (AD) wherein environmental causes are implicated (95 % etiology). The data suggest that GAQDs are a multifunctional carbon-based sustainable nano-platform at the intersection of nanotechnology and neuroprotection for advancing green chemistry-derived, sustainable healthcare solutions.

Graphene Quantum Dots Modulate Stress Granule Assembly and Prevent Abnormal Phase Transition of Fused in Sarcoma Protein

Halogen doped graphene quantum dots modulate TDP-43 phase separation and aggregation in the nucleus

Friend or Foe: the Role of Stress Granule in Neurodegenerative Disease

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function

In silico study on graphene quantum dots modified with various functional groups inhibiting α‑synuclein dimerization

Destabilization of Human Islet Amyloid Polypeptide Fibrils by Charged Graphene Quantum Dots: A Molecular Dynamics Investigation with Implications for Nanomedicine

Graphene quantum dots prevent alpha-synucleinopathy in Parkinson's disease

Hsp27 Chaperones FUS Phase Separation under the Modulation of Stress-Induced Phosphorylation

Lsm7 phase-separated condensates trigger stress granule formation

A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules

Hyperosmotic-stress-induced liquid-liquid phase separation of ALS-related proteins in the nucleus

Asymmetric dimethylation amplifies stress granule assembly via phase separation

Graphene acid quantum dots: A highly active multifunctional carbon nano material that intervene in the trajectory towards neurodegeneration

Gram-scale Synthesis of Single-Crystalline Graphene Quantum Dots with Superior Optical Properties

Targeting stress granules: A novel therapeutic strategy for human diseases

Metastable condensates suppress conversion to amyloid fibrils

Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy

Stress Granule: A Promising Target For Cancer Treatment

Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer's Disease

Stress granule formation via ATP depletion-triggered phase separation